(Q45748055)

15 December 2017

title

Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo (English)

1 reference

15 December 2017

author name string

K Sudo

1

1 reference

15 December 2017

W Watanabe

2

1 reference

15 December 2017

S Mori

3

1 reference

15 December 2017

K Konno

4

1 reference

15 December 2017

S Shigeta

5

1 reference

15 December 2017

T Yokota

6

1 reference

15 December 2017

publication date

1 May 1999

1 reference

15 December 2017

Antiviral Chemistry & Chemotherapy

published in

1 reference

15 December 2017

volume

10

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

135-139

1 reference

15 December 2017

Experimental respiratory syncytial virus infection of four species of primates

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Ribavirin: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Primary respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Ribavirin treatment of experimental respiratory syncytial viral infection. A controlled double-blind study in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

In vivo inhibition of respiratory syncytial virus by ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

New neplanocin analogues. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000305

10.1177/095632029901000305

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017